复发低级别胶质瘤第三次手术的清醒映射策略:功能与肿瘤学结局
该研究连续纳入31例复发弥漫性低级别胶质瘤(DLGG)患者,评估在清醒映射下进行第三次功能性切除术的可行性和功能与肿瘤学结局。结果显示第三次切除后仅1例遗留轻度找词困难,84.6%患者重返工作;7年和10年生存率分别为100%和89.7%,估计中位总生存期自诊断起为17.8年。
要点
- 复发DLGG第三次功能性切除术在清醒映射下可行,神经功能风险低。
- 第三次术后84.6%患者重返工作,仅1例遗留轻度找词困难。
- 在恶性转化前再次手术者残留肿瘤体积更小、切除程度更高。
核心结论
- 在选择的进展性DLGG患者中,第三次功能性切除术可在清醒映射下完成,神经功能风险低且全切除率高,尤其在恶性转化前再次手术时。
研究设计与样本
- 连续纳入31例接受第三次功能性切除术的复发DLGG患者,术中采用清醒映射,按肿瘤再生长速度或随访中出现影像增强分为两组。
主要发现
- 第三次切除后除1例遗留轻度找词困难外无持续神经功能缺损,84.6%患者重返工作。
- 自诊断起中位随访13.1±3.4年,自第三次手术起中位随访3.1±2.9年;7年和10年生存率分别为100%和89.7%,估计自诊断起中位总生存期17.8年。
- 组2的Karnofsky功能状态评分降至80以下更早(14.3 vs 17.1年,p=0.01)。
- 组1第三次手术时中位残留肿瘤体积更小(2.8 vs 14.4 cm3,p=0.003),切除程度更高(89% vs 70%,p=0.003)。
临床怎么用
- 对选择性的进展性DLGG患者,可考虑在清醒映射下实施第三次功能性切除术以最大化安全切除。
- 在恶性转化前进行再次手术可能获得更小的残留肿瘤体积和更高的切除程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Maximal safe resection is the first treatment in diffuse low-grade glioma (DLGG). Due to frequent tumor recurrence, a second surgery has already been reported, with favorable results. This study assesses the feasibility and functional and oncological outcomes of a third surgery in recurrent DLGG. METHODS: Patients with DLGG who underwent a third functional-based resection using awake mapping were consecutively selected. They were classified into group 1 in cases of slow tumor regrowth or group 2 if a radiological enhancement occurred during follow-up. All data regarding clinicoradiological features, histomolecular results, oncological treatment, and survival were collected. RESULTS: Thirty-one patients were included, with a median age of 32 years. There were 20 astrocytomas and 11 oligodendrogliomas in these patients. Twenty-one patients had medical oncological treatment before the third surgery, consisting of chemotherapy in 19 cases and radiotherapy in 8 cases. No neurological deficit persisted after the third resection except mild missing words in 1 patient, with 84.6% of the patients returning to work. The median follow-up duration was 13.1 ± 3.4 years since diagnosis, and 3.1 ± 2.9 years since the third surgery. The survival rates at 7 and 10 years were 100% and 89.7%, respectively, with an estimated median overall survival of 17.8 years since diagnosis. A comparison between the groups showed that the Karnofsky Performance Scale score dropped below 80 earlier in group 2 (14.3 vs 17.1 years, p = 0.01). Median residual tumor volume at the third surgery was smaller (2.8 vs 14.4 cm3, p = 0.003) with a greater extent of resection (89% vs 70%, p = 0.003) in group 1. CONCLUSIONS: This is the first consecutive series showing evidence that, in select patients with progressive DLGG, a third functional-based surgery can be achieved using awake mapping with low neurological risk and a high rate of total resection, especially when reoperation is performed before malignant transformation.
引用
- Hamdan N, Duffau H. Extending the multistage surgical strategy for recurrent initially low-grade gliomas: functional and oncological outcomes in 31 consecutive patients who underwent a third resection under awake mapping. J Neurosurg. 2021. PMID: 34507287. doi:10.3171/2021.3.JNS21264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。